Rwanda vs Tunisia: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Rwanda
96.0%
in 2025
Tunisia
96.0%
in 2025
Rwanda rank
27th
Tunisia rank
27th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Rwanda
- Tunisia
How they compare
Rwanda currently reports 96.0% against 96.0% in Tunisia, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Tunisia ahead.
Rwanda ranks 27th and Tunisia ranks 27th of 194 countries.
Across the 3 decades both report, Rwanda averaged higher in 1 and Tunisia in 1.
Head to head by decade
| Decade | Rwanda | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 97.7% | 0.0% | 97.7% | Rwanda |
| 2020s | 94.0% | 95.2% | 1.2% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Rwanda or Tunisia?
- Rwanda, at 96.0% against 96.0% in Tunisia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Rwanda and Tunisia?
- 0.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Tunisia?
- 18 years are reported by both, from 2008 to 2025.
- How do Rwanda and Tunisia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Rwanda ranks 27th and Tunisia ranks 27th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.